Tracer library / metaiodobenzylguanidine (MIBG)

metaiodobenzylguanidine (MIBG)

Also written as MIBG; metaiodobenzylguanidine (MIBG)
Radionuclide
Modality
—
Production route
—
Stage
—
Syntheses indexed
0
Pheochromocytoma and paraganglioma

What it is

Compound class
—
Target / mechanism
—
Clinical application
Diagnosis of pheochromocytoma/paraganglioma PMID 32446227
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. Giant Cystic Pheochromocytoma Associated With Neurofibromatosis Type 1: A Case Report.
    2024 · Cureus · Clinical study
  2. Diagnosis and treatment of a diaphragmatic pheochromocytoma: A case report.
    2020 · Int J Surg Case Rep · Clinical study

Need this precursor?We can point you to suppliers for metaiodobenzylguanidine (MIBG), or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 32446227, 38864044. Stage 40 (2026-10-05) duplicate check against i123-mibg / i131-mibg: same ligand, but NOT merged -- neither source article states the isotope (PMID 32446227: abstract and open full text, PMC7242994, say only 'MIBG scan'; PMID 38864044: abstract the same, full text not open access), so picking I-123 or I-131 would be a guess. Bare 'MIBG' is already an alternative name of both existing rows.